Contact Us

Yes. MSLN rescue experiments require attention to GPI-anchored protein topology: • Construct design: use a codon-modified MSLN sequence with a small N-terminal or internal tag (FLAG, HA) — MSLN has C-terminal GPI signal that is cleaved during processing, so C-terminal tags will be lost. • Surface localization validation: confirm GPI-anchored plasma membrane localization by cell surface staining and PI-PLC sensitivity before functional assays. • Furin processing: MSLN is processed by furin into MPF (released) and the C-terminal 40 kDa MSLN (cell-surface) — rescue interpretation considers processing. • Functional readout: rescue should restore CA-125/MUC16 binding (in vitro binding or co-culture assays) and antibody/CAR-T recognition for therapeutic validation. HEK293T transduces with very high efficiency and supports systematic rescue experiments — ideal for MSLN-targeted therapeutic specificity testing.

Yes. B2M rescue in A-549 supports NSCLC immunotherapy research: • Construct design: same considerations as B2M/HEK293T rescue. • NSCLC tumor antigen presentation: WT B2M rescue restores MHC I-restricted neoantigen presentation in NSCLC context. • Pembrolizumab/nivolumab response: in heterologous tumor-T cell co-culture systems, anti-PD-1-induced tumor killing should be restored by B2M rescue. • Functional readout: rescue should restore HLA-ABC surface expression and CD8+ T cell recognition. A-549 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying B2M in NSCLC context for checkpoint inhibitor resistance and lung cancer immunotherapy research. The Knockout line is the standard tool for asking whether B2M is required for these processes in NSCLC context — B2M loss-of-function is a documented mechanism of acquired resistance to pembrolizumab/nivolumab in NSCLC. Overexpression is useful for studying B2M gain-of-function effects. For NSCLC immunotherapy research, the EDITGENE B2M Knockout in A-549 is highly relevant — A-549 is an NSCLC cell line, and B2M loss has been characterized in pembrolizumab/nivolumab-resistant NSCLC patient tumors. This product complements the parallel B2M Knockouts in HEK293T (biochemistry) and A-375 (melanoma) for cross-background validation. Rescue with WT B2M is the standard specificity control. The knockout is valuable for studying NSCLC immune evasion mechanisms and emerging immunotherapy resistance approaches.

Yes. SIRT2 rescue experiments require attention to cytoplasmic targeting: • Construct design: use a codon-modified Sirt2 sequence with a small C- or N-terminal tag (FLAG, HA). SIRT2 has multiple isoforms with distinct N-termini — choose the isoform appropriate to the experimental question. • Catalytically-dead rescue: the H187Y mutation abolishes deacetylase activity and is the standard specificity control. • Tubulin deacetylation rescue: restoration of acetyl-tubulin levels by Western blot confirms catalytic rescue. • Inflammatory rescue: NLRP3 inflammasome and inflammatory cytokine production should be restored to confirm immune-relevant rescue. MH-S is a murine alveolar macrophage cell line — transduction with lentivirus is supported but may require optimization compared to non-macrophage lines.

The choice depends on whether you are studying SIRT2's role as a cytoplasmic NAD⁺-dependent deacetylase or its functions in macrophage immunology and inflammatory response. The Knockout line is the standard tool for asking whether SIRT2 is required for tubulin deacetylation, NLRP3 inflammasome regulation, and microglial/macrophage immune signaling — particularly relevant in MH-S, a mouse alveolar macrophage cell line. Overexpression is useful for studying SIRT2's effects on inflammation or cancer biology. For macrophage immunology research, the EDITGENE Sirt2 Knockout in MH-S is highly informative — MH-S is the standard murine alveolar macrophage model, and SIRT2 has emerging roles in macrophage polarization, inflammatory cytokine production, and NLRP3 inflammasome activity. Rescue with wild-type or catalytically-dead (H187Y) SIRT2 is the standard specificity control. SIRT2-selective inhibitors (AGK2, AK-7) specificity testing benefits from this knockout.

Yes, and rescue experiments are uniquely valuable for isoform-specific studies: • Construct design: use codon-modified PKM1 or PKM2 isoform-specific cDNAs (differ in exon 9 versus exon 10) with small C-terminal tags (FLAG, HA). Each isoform has the same catalytic architecture but different regulatory properties. • Isoform-specific rescue: separate rescue with PKM1 (constitutively active tetramer) or PKM2 (allosterically regulated) enables comprehensive isoform-function studies. • Allosteric mutant rescue: PKM2 K433E mutation disrupts FBP allosteric activation, useful for studying PKM2 regulation. • Functional readout: rescue should restore pyruvate kinase activity and glycolytic flux; isoform-specific rescue reveals distinct metabolic and proliferation phenotypes. A-549 transduces efficiently with lentivirus and supports systematic isoform-specific rescue experiments.

The choice depends on whether you are studying PKM (pyruvate kinase muscle isoform)'s role in glycolysis or its functions as the principal Warburg-effect-associated PKM2 isoform in cancer. The Knockout line is the standard tool for asking whether PKM is required for cellular pyruvate generation — PKM produces two splice isoforms, PKM1 (constitutively active tetramer) and PKM2 (allosterically regulated, dimer-tetramer dynamic), with PKM2 predominating in cancer cells and supporting metabolic flexibility through reduced enzymatic activity. Overexpression is useful for studying isoform-specific PKM functions or for testing PKM2 activators. Important consideration: PKM knockout eliminates both PKM1 and PKM2 isoforms — PKLR (liver-erythrocyte PK) provides limited compensation in non-hepatocyte contexts. For cancer metabolism research, the EDITGENE PKM Knockout in A-549 is highly relevant — A-549 is an NSCLC model expressing predominantly PKM2 isoform, and PKM2 is a validated cancer metabolic target. Rescue with isoform-specific cDNAs (PKM1 versus PKM2) enables comprehensive isoform-function studies. The knockout is a critical specificity control for PKM2 activators (TEPP-46, DASA-58) and PKM2-selective inhibitors in cancer drug development.

Yes, and rescue experiments are uniquely powerful in this double knockout: • Single-isoform rescue: re-introduction of GNB1 alone or GNB2 alone enables paralog-specific functional dissection — gold-standard experimental design. • Construct design: use codon-modified GNB1 or GNB2 sequences with small C-terminal tags (FLAG, HA). Gβ subunits have seven-bladed WD40 propeller architecture — preserve domain integrity. • Gγ partnership: Gβ subunits require Gγ for stability — rescue interpretation considers Gγ availability. • GNB1 oncogenic mutation rescue: K57E and other GNB1 cancer mutations enable disease genotype-function studies. • Functional readout: rescue should restore Gβγ-dependent signaling (PLCβ, PI3K, GIRK channels). HEK293 transduces efficiently with lentivirus and supports systematic isoform-specific rescue experiments.

The choice depends on whether you are studying combined Gβ1/Gβ2 function or distinguishing Gβ1/Gβ2-dependent from Gβ3/Gβ4/Gβ5-dependent G-protein signaling. The Double Knockout line is uniquely valuable for asking whether Gβ1/Gβ2 are required for these processes — GNB1 (Gβ1) and GNB2 (Gβ2) are the two most highly and broadly expressed Gβ subunits, sharing >90% sequence identity and substantial functional overlap as part of Gβγ dimers that signal through PI3K, PLCβ, GIRK channels, and adenylyl cyclase. Combined GNB1+GNB2 loss eliminates the dominant Gβ pool. Single-isoform rescue (GNB1 alone or GNB2 alone) enables paralog-specific functional dissection. For G-protein signaling research, the EDITGENE GNB1 & GNB2 Double Knockout in HEK293 is the gold-standard genetic tool — combined loss is required to eliminate Gβ1/Gβ2-dependent signaling. GNB3, GNB4, GNB5 paralog expression analysis aids interpretation. Single-isoform rescue is the gold-standard experimental design for paralog dissection. The double knockout is valuable for studying somatic GNB1 mutations in cancer (K57E activating mutations in myeloid malignancies) and emerging Gβγ-targeted therapeutics.

Yes, and rescue experiments are uniquely powerful in this double knockout: • Single-isoform rescue: re-introduction of DTWD1 alone or DTWD2 alone in the double knockout enables position-specific functional dissection (DTWD1 modifies position 20; DTWD2 modifies position 20a) — gold-standard experimental design for paralog dissection. • Construct design: use codon-modified DTWD1 or DTWD2 sequences with small C-terminal tags (FLAG, HA). Preserve DTW domain integrity in each paralog. • Catalytically-dead rescue: active site mutations enable separation of catalytic from structural functions. • Functional readout: rescue should restore position-specific acp³U levels and reverse the growth retardation phenotype reported in double knockout cells. HEK293 transduces efficiently with lentivirus and supports systematic isoform-specific rescue experiments.

The choice depends on whether you are studying combined DTWD1/DTWD2 function or distinguishing complete acp³U-deficient phenotypes. The Double Knockout line is uniquely valuable for asking whether DTWD1/DTWD2 are required for global acp³U tRNA modification — DTWD1 and DTWD2 catalyze acp³U at different tRNA positions (DTWD1 at position 20, DTWD2 at position 20a); combined loss eliminates acp³U at both positions, generating completely acp³U-deficient tRNAs. Single-isoform rescue (DTWD1 alone or DTWD2 alone) in the double knockout enables position-specific functional dissection. For tRNA modification research, the EDITGENE DTWD1 & DTWD2 Double Knockout in HEK293 is the gold-standard genetic tool — Takakura et al. (Nature Communications 2019) reported that DTWD1+DTWD2 double knockout cells exhibit growth retardation, indicating that acp³U is physiologically important in mammals. Single-isoform rescue is the gold-standard experimental design for paralog dissection. The double knockout is uniquely valuable for studying acp³U-dependent tRNA biology, translation fidelity, and emerging tRNA modification-related disease research.

Yes. TLR7/8 rescue experiments are uniquely valuable in this double knockout background: • Single-receptor rescue: re-introduction of TLR7 alone or TLR8 alone in the double knockout background is the gold-standard experimental design for distinguishing receptor-specific functions, since the two receptors are functionally redundant for many ssRNA ligands. • Construct design: use codon-modified TLR7 or TLR8 sequences with C-terminal tags. Both are type I membrane proteins with endosomal localization — N-terminal signal peptides must be preserved. • Endosomal localization validation: confirm endosomal compartment localization by immunofluorescence (LAMP1, Rab9 co-staining) before functional assays. • Agonist selectivity studies: TLR7-selective agonists (gardiquimod) versus TLR8-selective agonists (VTX-2337/motolimod) and dual agonists (R848) can be directly compared in single-rescue lines. THP-1 is a suspension cell line — transduction is typically performed via spinoculation with lentivirus; consider PMA-induced differentiation context for functional readouts.

The choice depends on whether you are studying ssRNA virus sensing, vaccine adjuvant mechanisms, or the redundancy and specialization between TLR7 and TLR8. The double Knockout line is appropriate for asking whether TLR7 and TLR8 are required jointly for these processes — single TLR7 or TLR8 knockouts often show mild phenotypes due to functional redundancy, which the double knockout eliminates. Overexpression is useful for testing receptor-specific ligand selectivity or for sufficiency studies. For TLR7/8 research, the EDITGENE Double Knockout in THP-1 is highly informative for vaccine adjuvant development (R848/resiquimod and related TLR7/8 agonists are clinical-stage adjuvants) and antiviral immunity studies — THP-1 is the standard human monocytic cell line for innate immune signaling research. Rescue with TLR7 alone or TLR8 alone enables direct dissection of receptor-specific contributions in a clean double-knockout background, which is the gold standard experimental design for distinguishing TLR7 and TLR8 functions.

Yes, and rescue experiments are uniquely powerful in this double knockout: • Single-isoform rescue: re-introduction of ESYT2 alone or ESYT3 alone in the double knockout enables paralog-specific functional dissection — gold-standard experimental design. • Construct design: use codon-modified ESYT2 or ESYT3 sequences with small C-terminal tags (FLAG, HA). Preserve ER hairpin, SMP domain, and C2 domain architecture. • SMP-domain or C2-domain mutant rescue: enables structure-function dissection within each paralog. • ESYT1 residual: rescue interpretation considers residual ESYT1 expression contributing to ER-PM contact sites. • Functional readout: rescue should restore ER-PM contact site lipid transfer activity. HEK293 transduces efficiently with lentivirus and supports systematic isoform-specific rescue experiments.

The choice depends on whether you are studying combined ESYT2/ESYT3 function or distinguishing ESYT2/ESYT3-dependent from ESYT1-dependent ER-PM contact site functions. The Double Knockout line is uniquely valuable for asking whether ESYT2/ESYT3 are required for these processes — ESYT2 and ESYT3 share substantial functional overlap as ER-PM contact site lipid transfer proteins; single knockouts retain residual activity from the other paralog, while double knockout eliminates ESYT2/ESYT3 functions, leaving only ESYT1. Single-isoform rescue (ESYT2 alone or ESYT3 alone) in the double knockout enables paralog-specific functional dissection. For ER-PM contact site research, the EDITGENE ESYT2 & ESYT3 Double Knockout in HEK293 is the gold-standard genetic tool — combined loss eliminates the most-characterized ESYT family members. Single-isoform rescue (ESYT2 alone or ESYT3 alone) is the gold-standard experimental design for paralog dissection. ESYT1 paralog expression analysis aids interpretation. The double knockout is uniquely valuable for studying glycerophospholipid transfer dynamics, PI(4,5)P2 replenishment at PM, and emerging ESYT family-targeted approaches.